Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 27, 2011-2019, November 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marugami, M.
Right arrow Articles by Farber, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marugami, M.
Right arrow Articles by Farber, E.

Influence of 3-Methylcholanthrene on Liver Carcinogenesis in Rats Ingesting DL-Ethionine, 3'-Methyl-4-dimethylaminoazobenzene, and N-2-Fluorenylacetamide1

Masao Marugami, Nobuyuki Ito, Yoichi Konishi, Yoshio Hiasa and Emmanuel Farber

Department of Pathology, Nara Medical University, Kashihara, Nara, Japan, and the Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15213

The purpose of this study was to observe whether the administration of 3-methylcholanthrene (3-MC) would influence the development of liver cancer by ethionine. Unlike the prevention by 3-MC of liver cancer induction by 3'-methyl-4-dimethylaminoazobenzene or 2-fluorenylacetamide, 3-MC had no evident influence upon the development of preneoplastic or neoplastic changes in the liver induced by ethionine. These findings are consistent with the conclusion that metabolism of ethionine by microsomal enzymes is not essential for liver carcinogenesis with this methionine analog.

1 Supported in part by research grants from the American Cancer Society and the Beaver County Cancer Society and by USPHS Research Grant CA-06074 from the National Cancer Institute. A preliminary report of some of this research has been published (10).

Received 3/ 6/67. Accepted 6/22/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1967 by the American Association for Cancer Research.